ImageneBio (IMA) Operating Expenses (2020 - 2025)
ImageneBio (IMA) posted Operating Expenses of $26.6 million for Q3 2025, up 203.93% sequentially from $8.8 million in Q2 2025, and up 380.38% YoY from $5.5 million in Q3 2024.
ImageneBio (IMA) Operating Expenses (2020 - 2025) Analysis & Trends
ImageneBio has reported Operating Expenses for 6 years, with the latest figure at $26.6 million in Q3 2025.
- Quarterly Operating Expenses rose 380.38% year-over-year to $26.6 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $42.1 million (down 34.36% YoY) and the FY2024 annual result came in at $59.0 million, down 30.27% from the prior year.
- Operating Expenses improved to $26.6 million in Q3 2025 per IMA's latest filing, from $8.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $26.6 million in Q3 2025 and troughed at $5.5 million in Q3 2024.
- A 5-year average of $18.0 million and a median of $20.3 million in 2022 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses slumped 73.24% in 2024, then jumped 380.38% in 2025.
- Over 5 years, Operating Expenses stood at $17.4 million in 2021, then advanced by 18.01% to $20.6 million in 2022, then rose by 9.74% to $22.6 million in 2023, then advanced by 9.08% to $24.6 million in 2024, then rose by 8.04% to $26.6 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $26.6 million, $8.8 million, and $6.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26.59 Mn |
| Jun 30, 2025 | 8.75 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 24.62 Mn |
| Sep 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 15.82 Mn |
| Mar 31, 2024 | 18.23 Mn |
| Dec 31, 2023 | 22.57 Mn |
| Sep 30, 2023 | 20.69 Mn |
| Jun 30, 2023 | 20.49 Mn |
| Mar 31, 2023 | 20.83 Mn |
| Dec 31, 2022 | 20.56 Mn |
| Sep 30, 2022 | 24.28 Mn |
| Jun 30, 2022 | 21.33 Mn |
| Mar 31, 2022 | 20.35 Mn |
| Dec 31, 2021 | 17.43 Mn |
| Sep 30, 2021 | 18.27 Mn |
| Jun 30, 2021 | 16.24 Mn |
| Mar 31, 2021 | 13.19 Mn |
| Dec 31, 2020 | 26.12 Mn |